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Simple Summary: Nowadays, thanks to the increased awareness of owners and breeders and to
the most recent techniques available to veterinarians, the management of parturition, especially of
C-sections, has become a topic of greater importance. Anesthesia is crucial and must be targeted
to both the mother and neonates. The present study aimed to evaluate the effect of the induction
agent alfaxalone on the vitality of puppies born from elective C-section, in comparison to propofol.
After inducing general anesthesia for elective C-section, puppies from the mothers induced with
alfaxalone had higher 5-min Apgar scores than those induced with propofol. The concentration of
cortisol in fetal fluids collected at birth is neither influenced by the anesthetic protocol used, nor
does it differ between amniotic and allantoic fluids. Nevertheless, the cortisol concentration in fetal
fluids affects the relationship between anesthesia and the Apgar score: the present study highlights
a significant relationship between the anesthetic protocol used and Apgar score in puppies, and
fetal fluids cortisol concentration acts as a covariate of this relationship. Alfaxalone is a safe and
effective drug for the induction of anesthesia in dogs, and it can be successfully employed for elective
C-section, with neonatal wellbeing improvements.
Abstract: Attention must be paid to C-section anesthesia effects on mother and offspring. Alfaxalone
induction results in improved puppy viability when compared to propofol. The present study aims
to evaluate effects of alfaxalone or propofol induction for elective C-section on newborns, expressed
as Apgar score and fetal fluids cortisol concentration. Anesthesia was induced with alfaxalone
3 mg/kg iv in 5 bitches (group A), and propofol 4 mg/kg iv in another 5 (group P), maintained with
isoflurane. Amniotic and allantoic fluids were collected to determine cortisol concentration. Apgar
score, litter size, newborn gender, birth-weight, maternal age, and parity were recorded. ANOVA, U
Mann-Whitney test and ANCOVA assessed the effects of drugs on the Apgar score and fetal fluids
cortisol. Thirty-six puppies were randomly selected for the study: 16 from group A and 20 from group
P. Only the Apgar score significantly differed between groups. ANCOVA confirmed a significantly
higher Apgar score in group A underlining the influence of fetal fluids cortisol concentrations, both
resulting in covariates. Present results confirm the effect of anesthesia on the Apgar score of newborns,
which is significantly higher for alfaxalone than propofol, suggesting the use of fetal fluids cortisol
as a covariate. These findings could be a starting point for further investigations when less viable
puppies are detected or expected, such as during an emergency C-section.
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1. Introduction
In dogs, as in other species, at Caesarean sections (C-sections) that are either planned or occur in an
emergency, particular attention must be paid to anesthesia effects on both the mother and the offspring.
On the maternal side, the so-called “gestational anti-nociception” must be taken into account [1–3],
allowing reduced drug dosages by 25% [4], and decreasing the isoflurane mean alveolar concentration
(MAC) by 28%/40% [5,6]. The latter is reported in ewes [5] and humans [6], but it can be reasonably
extended to other species, including dogs. This aspect is particularly relevant since, on the offspring
side, many anesthetic agents cross the placenta and the fetal blood-brain barrier, leading to a variable
extent of neurological and cardio-respiratory depression that could impair newborn viability [4].
At term, pregnant dogs need a 5-min pre-oxygenation to face the reduction of the residual
pulmonary volume [7]. Moreover, even if the existence of the aorto-caval syndrome was never
demonstrated in dogs [8–10], a supplementary fluid therapy must be given to face the potential
systemic hypotension, resulting from the extraction of the uterus from the abdomen, in a so called
“vacuum phenomenon” [11].
A standardized anesthetic protocol for C-section does not exist in dogs. Current practice in
anesthesia prefers to assess each patient and come up with individual protocols based on patient
presentation, history, procedure, and physical examination. Moreover C-section anesthesia implies
several specific prerequisites to be satisfied: maneuverability, minimum cardio-respiratory depression,
total reversibility of side effects on neonates, long-lasting analgesia, fast and safe maternal awakening,
and suitable care of the offspring [12,13].
The impact of anesthesia at C-section on outcomes for puppies is an important issue in canine
reproduction. In the last years, several studies have been performed to assess the best protocol
aimed to reduce fetal distress and maximize neonatal outcome [13–16]. However, the study of the
possible effect of a drug on fetal distress and neonatal outcome could be affected by several factors,
namely the methods to assess fetal distress or newborn viability, the clinical requirement of C-section
(emergency or planned), and the type of anesthesia protocol [13–16]. Furthermore, also the health and
the management of the pregnant bitch could influence the fetal well-being and development [17,18],
and, when an elective C-section is planned, also the identification of the correct day for surgery, in
terms of physiologic end of pregnancy and fetal maturation for birth is pivotal [18–24].
At a C-section, thyopental, ketamine, xylazine, and methoxyflurane should definitely be
avoided [25,26].
Propofol induction followed by isoflurane maintenance has positive effects on neonatal survival
at 7 days [27]. Propofol is a sedative-hypnotic agent, which induces depression by enhancing the
effects of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) [28]. Chemically, it is
represented by a phenolic compound, only slightly soluble in water, which is marketed as an aqueous
emulsion [29]. This mixture contains, among other ingredients, egg lecithin, which makes propofol
able to support microbial growth and endotoxin production, thus this product must be handled
carefully [29]. Propofol has a rapid onset of action, thanks to its fast uptake in the central nervous
system, a large volume of distribution, by its highly lipophilic nature, and a quite fast disappearance
from plasma, via hepatic metabolism, primarily based on conjugation pathways, and mainly urinary
excretion [30]. Propofol decreases intracranial and cerebral perfusion pressure, and, as a result of arterial
and venous vasodilation, it transiently decreases arterial pressure and myocardial contractility [31].
Patients induced in general anesthesia with propofol can experience a brief period of apnea, followed
by a short phase of hypercapnia, particularly if the intravenous administration occurs too fast [32].
In 2004, Luna and colleagues have demonstrated that the optimal procedure for anesthesia at
C-section is represented by a loco-regional epidural technique, but it has technical drawbacks of
undesired prolonged paralysis, hypo-tension, and restlessness, that may lead to the induction of
general anesthesia [33].
Alfaxalone, a steroidal molecule with GABA-agonist action that was recently introduced on
the Italian veterinary market, shows many features, making it particularly suitable for small animal
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anesthesia in the obstetrical field, especially for C-sections. Alfaxalone leads to a quick and smooth
induction of general anesthesia, with a subsequent rapid recovery and minimum respiratory depression;
it is characterized by a wide maneuverability, fast clearance, and short plasmatic half-life [34,35].
At the end of the twentieth century, alfaxalone was commonly used, especially in feline medicine, in a
commercial formulation known as “saffan”, a mixture of alfaxalone and alfadolone solubilized by an
oily cromophore [36]. The latter was responsible for severe anaphylactic reactions in dogs, mediated
by a huge histamine release, which limited the use of the drug in clinical practice, with the constant
necessity of a premedication with anti-histaminic agents [37]. Nevertheless, already in 1981, Bomzon
reported the use of alfaxalone in bitches undergoing C-section, describing it as a safe and predictable
inductor for general anesthesia, with higher properties if compared to thyopental anesthesia [38].
Subsequently, a new formulation of alfaxalone was introduced on the market, dedicated to small
animal anesthesia, thanks to a new solubilizing agent, represented by cyclodextrines, not inducing
hystamine release in the dog [35,39].
In dogs, anesthesia induction with alfaxalone at emergency C-section was recently related to higher
newborn viability, assessed by Apgar score, in comparison to propofol [14]. Anesthesia induction with
alfaxalone at elective and emergency C-section was also qualified as equivalent to propofol in terms of
neonatal vitality [15], but in this case the evaluation of puppies was less objective as it was assessed
scoring straightening, suction, ano-genital, and flexion reflexes. Finally, anesthesia maintenance by
alfaxalone in continuous rate infusion (CRI) was attempted at elective C-section, but its results were
inadvisable in clinical practice compared to isoflurane, because it lowers the neonatal Apgar score and
maternal recovery quality, and it requires repeated rescue boluses and high total dosages of alfaxalone,
implying slow procedures [16]. The lighter depth of anesthesia obtained by alfaxalone CRI was also
supposed to be responsible for a higher arterial blood pressure [16].
Concerning the objective evaluation of the impact of anesthesia on puppies, veterinary
neonatologists have to face the limited possibilities for blood-gas analysis or other investigations that
could harm the health of small and fragile newborn puppies. Recently, the Apgar score, and the cortisol
concentration in amniotic and allantoic fluids were suggested as neonatal parameters possibly affected
by the delivery management [17,40–42]. The Apgar score evaluation, introduced 10 years ago by
Veronesi and colleagues [40,41], provides a simple and useful tool for the evaluation of canine newborns.
In particular, it represents the easiest tool for estimating neonatal viability [40,41]; thus, its evaluation
allowed a comparison of the effect of different drugs used at C-sections in some studies [14,16]. On the
other hand, thanks to their easy and safe collection at C-sections, fetal fluids have been reported as
being useful for newborn puppies evaluation at birth, too [42–44]. Among fetal fluids compounds,
amniotic and allantoic cortisol, as the final products of the hypothalamus-pituitary-adrenal (HPA)
axis activation, have been reported as possible markers for newborn assessments and to detect those
puppies requiring special surveillance in the first 24 h of life [42]. Therefore, since both parameters were
related to the short-term survival of newborn dogs, fetal fluids cortisol concentrations analysis, together
with the Apgar score assessment, provides a tool for the evaluation of canine newborns [40–42].
The aim of the present study was to evaluate the effect of alfaxalone or propofol, used to induce
general anesthesia for elective C-section in giant-breed dogs, on newborn viability, measuring the
neonatal Apgar score and fetal fluids cortisol concentration.
2. Materials and Methods
2.1. Ethics
The study was performed in accordance with the animal welfare committee ethical guidelines
and all procedures were carried according to the Italian legislation on animal care (DL 116, 27/01/1992)
and the European Guidelines on Animal Welfare (Directive 2010/63/EU). A written informed owner
consent was obtained, not only to submit pregnant dogs to elective C-section, but also for the collection
of clinical records and fetal fluids for research purposes.
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2.2. Animals
Ten giant-size purebred bitches (53–75 kg body-weight; 2–6 years of age; 1–3 parity) belonging
to four breeds (Great Dane, Newfoundland, Maremmano, Saint Bernard) were enrolled. All sourced
animals were client owned, and housed in the respective kennels. All bitches were proven to be
healthy at the breeding soundness examination (time of patients recruitment) performed before the
beginning of pregnancy in order to avoid the effect of maternal illness on perinatal health [45,46].
The breeding soundness examination included the clinical history of the bitch, a physical examination
(general objective examination, combined with an objective examination of the reproductive organs),
a haemochromocytometric exam, a biochemical profile, and an ultrasonographic exam of the whole
reproductive tract. They all were fed with the same commercial diet according to metabolic requirements
for gestation, according to veterinary suggestions. No remarkable differences existed in the pregnancy
management that could artificially enhance different neonatal viability and maternal or fetal stress in
any of the groups. Only pregnancies without complications, showing normal fetal development, as
assessed by fetal biometry, were kept in the study [17,19,20]. Because of previous history or prediction
of troubles at parturition, C-section was, in all cases, planned for the health of mothers and puppies.
2.3. Procedure
Because of the importance of ensuring the correct matching between the calculated day of an
elective C-section and the actual term of pregnancy in relation to fetal preparation for birth [17], the
elective C-section was planned on the basis of several cumulative parameters. They were represented
by blood progesterone concentrations (MiniVidas, BioMerieux, Marcy l’Etoile, France) measured
during heat [19], prediction of parturition day, estimated by fetal biometry [20], and the confirmation
of approaching parturition by blood progesterone concentrations < 2 ng/mL [18]. Also, a clinical
monitoring of fetal well-being [47] and maternal impending parturition were daily assessed in the last
3-5 days preceding the expected date of parturition.
On the day of the C-section, the bitches were fasted for 12 h before surgery. [11]. No pre-medication
was given; an intravenous catheter was placed; 5-min pre-oxigenation and fluid therapy with ringer
lactate 5 mL/kg/h iv (Ringer Lattato, BBraun Milano Spa, Milano, Italy) were administered. Concerning
anesthesia, bitches were randomly assigned to alfaxalone (Alfaxan, Dechra Veterinary Products Srl,
Torino, Italy) 3 mg/kg iv (group A), or propofol (Proposure, Merial, Lyon, France) 4 mg/kg iv (group
P) anesthetic induction. Both drugs were administered via the iv catheter titrated to effect to reach
oro-tracheal intubation. Anesthesia was then maintained with isoflurane 2% (Vetflurane, Virbac,
Milan, Italy) in oxygen 90%–95%, delivered via an oxygen concentrator (Nuvo Mark 8, GCE Mediline,
Malmo, Sweden). An open circuit Mapleson type C was used. Isoflurane dosage was always verified
as expired isoflurane; its requirement was clinically assessed in order to maintain a surgical anesthesia
classified as stage III plane 2 [48]. Opioids (methadone 0.2mg/kg im, Semfortan, Dechra Veterinary
Products Srl, Torino, Italy) and NSAIDs (meloxicam 0.2mg/kg im, Inflacam, Virbac, Milan, Italy) were
administered only after the extraction of the last puppy.
The operating team always involved the same veterinarians: two surgeons, an anesthetist, two
neonatologists, and one person exclusively dedicated to fetal fluids collection. Surgeons, neonatologists,
and the person entrusted to collect fetal fluids were blind to the inductor agent used by the anesthetist.
The anesthetist randomly assigned bitches to group A or group P: the casual randomization assigned
bitches with odds enrolment number to group A and bitches with even enrolment number to group P.
The two neonatologists were of equal expertise and followed the same standardized procedures in the
assistance and clinical evaluation of puppies.
Amniotic and allantoic fluids were aseptically collected at fetal bags opening. Fluids were
immediately centrifuged at 1000 rpm for 10 min, supernatant was removed, and samples were frozen
at −20 ◦C to be later analyzed by Radio-Immuno Assay (RIA) for cortisol concentrations (Cortisol,
[1,2,6,7-3H (N)] PerkinElmer Life Sciences, Boston, MA, USA) by Top-Count (PerkinElmer Life Sciences,
Boston, MA, USA). Analysis was always performed within 3 months from fluid collection [42,43].
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The cortisol analysis in amniotic and allantoic fluids was performed following the procedure described
by Bolis and colleagues [42].
Sixty-nine healthy, viable [21,22,40], and normal-weighted [23,49,50] puppies were born. In order
to ensure the collection of both amniotic and allantoic fluids from the same puppy, and to reduce to
the minimum the possibility of mistakes between fetal fluids collection/identification and newborn
records, it was chosen not to sample entire litters, but around half of the total number of puppies from
each litter. Thus, among the sixty-nine newborns, thirty-six puppies were sampled: 16 from group
A bitches and 20 from group P bitches. Indicatively, every second puppy was sampled, allowing
an equal representation of puppies extracted at the beginning, in the middle, and at the end of the
C-section. The order of puppies at delivery was recorded, and no specific differences were appreciated.
A potential bias concerning puppies delivered last, which would be subjected to isoflurane for a longer
period than puppies delivered earlier, possibly affecting Apgar scores and cortisol concentrations,
could be suspected. However, in the present study, it would be present in both alfaxalone and propofol
groups, thus it does not affect the statistical comparison between the two groups. Moreover, groups A
and P were statistically proven not to be different concerning epidemiological parameters, including
the litter size.
Apgar score was assessed in all puppies 5 min after birth, and puppies were defined as viable
when the Apgar score was ≥7 [40].
Litter size, newborn gender and birth-weight, and maternal age and parity were also recorded.
2.4. Statistical Analysis
All obtained data were reported on Excel 2010 Office files, and mean values± SD were calculated for
each parameter. As Apgar score is a non-parametric ordinal variable, it was expressed as median value,
accompanied by assumed minimum and maximum values. All data were tested for normal distribution
by a Shapiro-Wilk test. The statistical analysis was performed by ANOVA, U Mann-Whitney test and
ANCOVA, to assess the effect of the two anesthetic drugs on Apgar score and fetal fluids cortisol
concentration, as well as the possible effect played by other maternal or neonatal parameters.
First of all, the ANOVA was used to compare enrolled litters and puppies numbers, male to
female ratio, birth-weight, litter size, maternal age and parity between the two study groups, in order
to verify the absence of any epidemiological difference between group A and P that, if present, could
have artificially biased results of the present study. Then, ANOVA was also used to compare cortisol
concentrations in amniotic and allantoic fluids within both groups, in order to verify similarities in their
trends. Finally, ANOVA was used to compare amniotic cortisol and allantoic cortisol concentrations,
while the U Mann-Whitney test was applied for Apgar scores, between the two study groups, in order
to verify the possible effects of the two induction protocols.
Furthermore, the possible effect played by other variables on the relationship existing between
the anesthetic induction protocol and Apgar score was assessed by ANCOVA, in which the type of
anesthetic induction protocol (alfaxalone or propofol) was considered as the independent variable
and the Apgar score as the dependent variable. Amniotic and allantoic cortisol concentrations and
epidemiological parameters (male to female ratio, birth-weight, litter size, maternal age and parity)
were evaluated as concomitant variables (alias possible covariates). The ANCOVA was chosen because
it is useful when the analysis of data of a certain variable is possibly associated to a covariate preventing
the creation of homogeneous groups to compare. In the present study, in order to evaluate the real
effect of anesthetic protocol induction on Apgar score, the cortisol level of amniotic and allantoic
fluids and epidemiological data could represent possible confounding factors, leading to biased results.
Theoretically, this problem could have been bypassed by forming homogeneous experimental groups
for each possible confounding covariate. This was not practically possible and even not so useful, since
the covariates were factors that could be measured. Moreover, since possible covariates taken into
account in the present study were continuous variables, it was more useful to use them as such and not
as limited intervals, which would not reflect the actual normal heterogeneity in concomitant variables
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levels, allowing us to determine the effect of the induction protocol only in those animals with a specific
level of the concomitant variables. Thus, the results would have not been generalizable and of scarce
relevance in clinical practice. Such an approach reduced the error variance due to heterogeneity and
corrected mean values of groups to obtain a correct estimate of the anesthesia induction effect on the
Apgar score.
Results were considered significant for p < 0.05. The statistical analysis was performed with
the online tools VassarStats: Website for Statistical Computation (http://vassarstats.net, Vassar
College, New York, NY, USA) and Social Science Statistics (https://www.socscistatistics.com, Jeremy
Stangroom, USA).
3. Results
Sixty-nine healthy, viable, and normal-weighted puppies were born. Among them, thirty-six
puppies were sampled: 16 from group A bitches and 20 from group P bitches. They all showed a
subsequent normal growth for the respective breeds, with no deaths reported in the first year of life.
The ANOVA statistical analysis did not show significant differences in cortisol concentrations
between amniotic and allantoic fluids, neither within nor between groups A and P (Table 1).
Table 1. Amniotic and allantoic cortisol concentrations measured in the 16 puppies belonging to group
A and in the 20 puppies belonging to group P, expressed as mean ± SD.
Group A
(n = 16)
Group P
(n = 20)
Amniotic cortisol (ng/mL)
(n = 36) 7.0 ± 2.4
a 6.7 ± 3.3 a
Allantoic cortisol (ng/mL)
(n = 36) 6.1 ± 2.7
a 5.8 ± 1.9 a
Equal superscripts denote the absence of statistically significant differences within columns and rows (p ≥ 0.05).
Similarly, clinical records, such as enrolled litters and puppies numbers, the male to female ratio,
birth-weight, maternal age and parity, and litter-size did not show statistically significant differences
between the two groups.
Conversely, the 5-min Apgar score was statistically (p <0.02) higher in group A than in group P
(Table 2).
Table 2. Clinical records (neonatal gender, birth weight, Apgar score, maternal age and parity and
litter-size) in group A and group P, expressed as mean ± SD. The APGAR score is expressed as a median
value, with the minimum and maximum in brackets.
Clinical Records Group A Group P
Litters (n) 5 a 5 a
Puppies (n) 16 a 20 a
Males (n)-Females (n) 8-8 a 10-10 a
Birth weight (g) 664.1 ± 185.9 a 794.5 ± 96.2 a
Apgar score 10 (10, 10) a 9 (8, 10) b
Litter size (puppies n) 7.5 ± 4.2 a 8.9 ± 3.4 a
Maternal age (years) 2.8 ± 1.3 a 4.8 ± 0.7 a
Maternal parity (n) 1.4 ± 0.6 a 2.0 ± 0.4 a
Different superscripts denote statistically significant differences within rows (p < 0.05).
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Finally, the ANCOVA confirmed the effect of anesthesia induction protocol on Apgar score,
significantly higher in group A than in group P (p < 0.05). Furthermore, it highlighted the role of
both amniotic and allantoic fluids cortisol concentrations as covariates on the relationship existing
between anesthesia induction protocol and 5-min Apgar score (p = 0.01 and p = 0.004, respectively).
No covariance effect was found concerning either maternal or neonatal epidemiological data.
4. Discussion
When elective C-section in dogs is required, the most important issue is the correct identification
of the date for surgery, managing to perform it when gestation reaches its real physiological end and
fetal maturity for birth [17]. This goal can be achieved only when multiple parameters are considered
together. For this reason, in the present study, blood progesterone concentration during heat [19]
was matched to fetal biometry formulae for the prevision of the day of expected parturition, to verify
the normal fetal development [20,24]. Finally, in order to increase precision of the estimation, blood
progesterone concentration decrease to pre-parturient values was assessed [18], while clinical and
ultrasonographic maternal preparation for birth was checked [47], as well as the fetal maturation of
some organs [22].
Therefore, in the present study, aimed to evaluate the comparison between two different protocols
for anesthesia induction on neonatal outcome at elective C-section, the date of surgery was scrupulously
identified, and Apgar score and cortisol concentration in both fetal fluids were assessed.
The U Mann-Whitney test showed a significantly higher Apgar score when anesthesia induction
was performed with alfaxalone rather than with propofol. Moreover, the ANCOVA suggested the role
of fetal fluids cortisol as covariate. This means that, allocating the same fluid cortisol concentration
to all puppies, the pharmacological effect on Apgar score would be even more significant. Under a
statistical point of view, detecting the heterogeneity factor represented by cortisol, the error variance
gets reduced and the positive effect of alfaxalone on puppy viability in terms of the Apgar score
is more markedly underlined. This result must be interpreted cautiously. In fact, the statistically
significant difference was found between puppies scored as median value 10 (minimum 10, maximum
10) in the A group vs. median value 9 (minimum 8, maximum 10) in P group, which means puppies
equally classified in the highest score of viability [40,41]. Even if the clinical relevance of this finding
is restrained, present results could be a starting point for further investigations in situations with
diagnosis or expectation of less viable puppies, such as at emergency C-section. In this setting, the
use of alfaxalone for anesthesia induction might be better than other protocols, because cortisol is
supposed to be higher due to the hyper-activation of the HPA-axis of both mother and fetuses [51], and
diverse anesthetic drugs might play a more pronounced role on newborn viability. In fact, the effect of
cortisol concentration in fetal fluids on the association between alfaxalone and higher Apgar scores
seems to suggest that the effect of alfaxalone on newborns better viability could be related to the fetal
HPA-axis activation [51]. However, based on actual knowledge about canine fetal maturation, it is not
possible to link this finding to puppies maturity. As such, it must be remarked that, in the present
study, all C-sections were planned before the beginning of spontaneous parturition, but as close as
possible to the physiologic term of pregnancy. At this time, fetuses are mature enough to adapt to
extra-uterine life and to survive after birth. In fact, apart from viability assessment by the Apgar score,
all the puppies were completely developed [44], healthy [22], and normal-weighted [23,49,50], and
showed a subsequent normal growth for the respective breeds [22,49], with no deaths reported in the
first year of life.
Present results can be compared to those obtained in previous studies [14–16], evaluating the
effect of alfaxalone on puppy outcomes at C-section. Different study design and procedures have
to be considered as they make a direct comparison of the results impossible [14–16]. Concerning
the peri-operative management of delivery, Doebeli and colleagues [14] only evaluated emergency
C-sections, Metcalfe and colleagues [15] enrolled both emergency and planned C-sections, without
differentiating results obtained in the two conditions, while Conde Ruiz and colleagues [16] considered
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only elective C-sections, using alfaxalone not only for general anesthesia induction, but also for
continuous rate infusion maintenance. However, the present study results are in agreement with
those reported by Doebeli and colleagues [14], that found no bias of elective or emergency conditions
at C-section on the anesthetic outcome of alfaxalone on neonatal viability at birth. On the other
hand, Metcalfe and colleagues [15], reported similar viability in puppies born from either elective
or emergency C-sections, independently of the drug used to achieve general anesthesia (alfaxalone
vs propofol), even if the evaluation of neonatal viability relied on a subjective scoring system of
straightening, suction, ano-genital, and flexion reflexes, reported by the authors to be less specific than
the Apgar scoring method [15]. In another study [16], a lower Apgar score was reported in association
to anesthesia maintenance with alfaxalone constant rate infusion compared to isoflurane in oxygen [16].
The lower Apgar score obtained, together with a worse maternal awakening, was ascribed to the
different employment of alfaxalone, while the higher intra-operative systemic blood pressure was
linked to the absence of isoflurane and a lighter plan of general anesthesia [16].
Operating procedures concerning the absence of pre-medication and the delay in the administration
of analgesics and NSAIDs after the extraction of the last puppy are common to mentioned
literature [14–16] and to the present study. Thus, it cannot be excluded that the administration
of different drugs at different time intervals might affect neonatal outcomes independently of the
anesthetic protocol used.
As previously stated, conversely to the above mentioned studies, in which the binomial relationship
between anesthesia induction protocol and the Apgar score was considered, in the present study
the statistical analysis also took in consideration the cortisol concentration in amniotic and allantoic
fluids, previously reported as indicators for 24 h survival prognosis [42]. In the authors’ opinion, this
allows a more objective evaluation of the role of the anesthetic induction protocol and its effect on
neonatal outcome.
A further consideration about the characteristics of the 2 study groups is fundamental. Conversely
to previous studies performed on bitches of different breeds, sizes, ages, and parities [14–16],
only giant-size purebred bitches were enrolled to avoid any possible confounding effect due to
size-specific variations. Moreover, the statistical analysis showed the absence of differences between
the two groups in terms of litter size, maternal age and parity, puppies sex ratio and birth-weight,
highlighting uniformity in the studied samples. In accordance with previous reports [42], none of the
above-mentioned parameter’s results were associated with fetal fluids cortisol concentrations.
Finally, alfaxalone gets benefits from its high safety, its fast clearance, and short half-life, following
the quick hepatic metabolism by esterases and the very efficient renal excretion, without massive
accumulations in body tissues [34,35]. Nevertheless, at term of pregnancy, the maternal hemodynamic
status undergoes a physiological overload due to gestation itself, especially in giant-size dogs [52–54],
and the low cardio-circulatory impact of alfaxalone at standard dosages (up to 3 mg/kg) [55] on the
maternal side is of paramount advantage.
Some features of the use of alfaxalone at C-section still need to be verified in structured studies,
meaning it would be useful to enroll and statistically compare results from elective and emergency
C-sections, as well as in dogs of different breed sizes, including a wider evaluation of the maternal side.
However, from a comprehensive evaluation of the literature available at present, alfaxalone can be
considered as a safe drug for anesthesia management at C-section.
5. Conclusions
In conclusion, the present study results, obtained from healthy, viable, and normal-weighted
puppies born by elective C-section performed at term in healthy giant-size purebred bitches, showed
a positive statistical association between anesthesia induction protocol with alfaxalone and a higher
Apgar score. Moreover, cortisol concentrations in amniotic and allantoic fluids are identified as
covariates of this relationship. These findings could be a starting point for further investigations when
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less viable puppies (and possibly higher cortisol concentrations in fetal fluids) are detected or expected,
such as at an emergency C-section.
Author Contributions: Conceptualization, M.M.; S.A. and M.C.V.; methodology, M.M. and S.A.; formal analysis,
M.M. and S.A.; investigation, M.M.; S.A.; M.C.V.; T.P. and B.B.; data curation, M.M. and S.A.; writing—original
draft preparation, M.M. and S.A.; writing—review and editing, M.M.; S.A.; T.P.; B.B. and M.C.V.
Funding: This research received no external funding.
Acknowledgments: Authors are grateful to Laura Colombi, certified translator for English language, for
linguistic support.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Dawson-Basoa, M.; Gintzler, A.R. Estrogen and progesterone activate spinal kappa-opiate receptor analgesic
mechanisms. Pain 1996, 64, 607–615. [CrossRef]
2. Dawson-Basoa, M.; Gintzler, A.R. Gestational and ovarian sex steroid antinociception: Synergy between
spinal κ and δ opioid systems. Brain Res. 1998, 794, 61–67. [CrossRef]
3. Okuda, K.; Iwasaka, H.; Hagiwara, S.; Takeshima, N.; Takatani, J.; Uchino, T.; Noguchi, T. The antinociceptive
effects of estradiol on adjuvant-induced hyperalgesia in rats involve activation of adrenergic and serotonergic
systems. J. Anaesth. 2011, 25, 392–397. [CrossRef] [PubMed]
4. Raffe, M.R.; Carpenter, R.E. Anaesthetic management of Caesarean Section patients. In Lumb & Jones’
veterinary anaesthesia and analgesia; Tranquilli, W.J., Thurmon, J.C., Grimm, K.A., Eds.; Blackwell Publishing:
Ames, IA, USA, 2007; pp. 955–967.
5. Palahniuk, R.J.; Shnider, S. Maternal and fetal cardiovascular and acid-base changes during halothane and
isoflurane anaesthesia in the pregnant ewe. Anaesthesiology 1974, 41, 462–472. [CrossRef]
6. Gin, T.; Chan, M.T. Decreased minimum alveolar concentration of isoflurane in pregnant humans.
Anesthesiology 1994, 81, 829–832. [CrossRef]
7. Pascoe, P.J.; Moon, P.F. Periparturient and neonatal anaesthesia. Vet. Clin. North. Am. Small Anim. Pract.
2001, 31, 315–340. [CrossRef]
8. Abitbol, M. Inferior vena cava compression in the pregnant dog. Am. J. Obstet. Gynecol. 1978, 130, 194–198.
[CrossRef]
9. Abitbol, M. Supine position in labour and associated fetal heart rate changes. Obstet. Gynecol.
1985, 65, 481–486.
10. Probst, C.W.; Broadstone, R.V.; Evans, A.T. Postural influence on systemic blood pressure in large full-term
pregnant bitches during general anesthesia. Vet. Surg. 1987, 16, 471–473. [CrossRef]
11. Kudnig, S.T.; Mama, K. Perioperative fluid therapy. J. Am. Vet. Med. Assoc. 2002, 221, 1112–1121. [CrossRef]
12. Greene, S.A. Anesthetic considerations for surgery of the reproductive system. Sem. Vet. Med. Surg.
(Small Anim.) 1995, 10, 2–7.
13. De Cramer, K.G.M.; Joubert, K.E.; Nothling, J.O. Puppy survival and vigor associated with the use of low
dose medethomidine premedication, propofol induction and maintenance of anesthesia using sevoflurane
gas-inhalation for caesarean section in the bitch. Theriogenology 2017, 96, 10–15. [CrossRef] [PubMed]
14. Doebeli, A.; Michel, E.; Bettschart, R.; Hartnack, S.; Reichler, I.M. Apgar score after induction of anesthesia
for canine cesarean section with alfaxalone versus propofol. Theriogenology 2013, 80, 850–854. [CrossRef]
[PubMed]
15. Metcalfe, S.; Hulands-Nave, A.; Bell, M.; Kidd, C.; Pasloske, K.; O’hagan, B.; Perkins, N.; Whittem, T.
Multicentre, randomised clinical trial evaluating the efficacy and safety of alfaxalone administered to bitches
for induction of anaesthesia prior to caesarean section. Aust. Vet. J. 2014, 92, 333–338. [CrossRef] [PubMed]
16. Conde Ruiz, C.; Del Carro, A.P.; Rosset, E.; Guyot, E.; Maroiller, L.; Buff, S.; Portier, K. Alfaxalone for
total intravenous anaesthesia in bitches undergoing elective caesarean section and its effects on puppies:
A randomized clinical trial. Vet. Anaesth. Analg. 2016, 43, 281–290. [CrossRef]
17. Alonge, S.; Melandri, M. Effect of delivery management on first-week neonatal outcome: How to improve it
in Great Danes. Theriogenology 2019, 125, 310–316. [CrossRef]
Animals 2019, 9, 962 10 of 11
18. Veronesi, M.C.; Battocchio, M.; Marinelli, L.; FAUSTINI, M.; Kindahl, H.; Cairoli, F. Correlations among body
temperature, plasma progesterone, cortisol and prostaglandin F2α of the periparturient bitch. J. Vet. Med.
2002, 49, 264–268. [CrossRef]
19. Levy, X.; Fontbonne, A. Determining the optimal time of mating in bitches: Particularities. Rev. Bras.
Reprod. Anim. 2007, 31, 128–134.
20. Alonge, S.; Beccaglia, M.; Melandri, M.; Luvoni, G.C. Prediction of whelping date in large and giant canine
breeds by ultrasonography foetal biometry. J. Small Anim. Pract. 2016, 57, 479–483. [CrossRef]
21. Melandri, M.; Alonge, S.; Veronesi, M.C. Urine specific gravity serial analysis in Great Dane dogs from birth
to 28 days of age. Reprod. Dom. Anim. 2017, 52, 139.
22. Melandri, M.; Barella, G.; Aiudi, G.; Lacalandra, G.M.; Alonge, S. Color flow mapping exam: An useful
screening test for the early diagnosis of ductus venosus patency in canine newborns. Reprod. Dom. Anim.
2018, 53, 1130–1135. [CrossRef] [PubMed]
23. Melandri, M.; Alonge, S.; Trovo’, C.; Beccaglia, M. Neonatal-maternal bodyweight ratio at birth: An indicator
for the first week survival prognosis in canine newborns. In Proceedings of the “21st EVSSAR congress”,
Venice, Italy, 22–23 June, 2018; p. 123.
24. Beccaglia, M.; Alonge, S.; Trovo’, C.; Luvoni, G.C. Determination of gestational time and prediction of
parturition in dogs and cats: An update. Reprod. Dom. Anim. 2016, 51, 12–17. [CrossRef] [PubMed]
25. Moon, P.F.; Erb, H.N.; Ludders, J.W.; Gleed, R.D.; Pascoe, P.J. Perioperative risk factors for puppies delivered
by cesarean section in the United States and Canada. J. Am. Anim. Hos. Assoc. 2000, 36, 359–368. [CrossRef]
[PubMed]
26. Moon-Massat, P.F.; Erb, H.N. Perioperative factors associated with puppy vigor after delivery by cesarean
section. J. Am. Anim. Hosp. Assoc. 2002, 38, 90–96. [CrossRef] [PubMed]
27. Funkquist, P.M.E.; Nyman, G.C.; Löfgren, A.J. Use of propofol-isoflurane as an anesthetic regimen for
cesarean section in dogs. J. Am. Vet. Med. Assoc. 1997, 211, 313–317.
28. Concas, A.; Santoro, G.; Serra, M.; Sanna, E.; Biggio, G. Neurochemical action of the general anesthetic
propofol on the chloride ion channel coupled with GABA receptors. Brain Res. 1991, 542, 225. [CrossRef]
29. Arduino, M.J.; Bland, L.A.; McAllister, S.K.; Aguero, S.M.; Villarino, M.E.; McNeil, M.M.; Jarvis, W.R.;
Favero, M.S.; Favero, M.S. Microbial growth and endotoxin production in the intravenous anesthetic propofol.
Infect. Control Hosp. Epidemiol. 1991, 12, 535. [CrossRef]
30. Langley, M.S.; Heel, R.C. Propofol: A review of its pharmacodynamic and pharmacokinetic properties and
use as an intravenous anesthetic. Drugs 1988, 35, 334. [CrossRef]
31. Ilkiw, J.E.; Pascoe, P.J.; Haskins, S.C.; Patz, J.D. Cardiovascular and respiratory effects of propofol
administration in hypovolemc dogs. Am. J. Vet. Res. 1992, 53, 2323.
32. Smith, I.; White, P.F.; Nathanson, M. Propofol, An update on its clinical use. Anesthesiology 1994, 81, 1005.
33. Luna, S.P.L.; Cassu, R.N.; Castro, G.B.; Neto, F.T.; Silva, J.R.; Lopes, M.D. Effects of four anaesthetic
protocols on the neurological and cardiorespiratory variables of puppies born by caesarean section. Vet. Rec.
2004, 154, 387–389. [CrossRef] [PubMed]
34. Ferré, P.J.; Pasloske, K.; Whittem, T.; Ranasinghe, M.G.; Li, Q.; Lefebvre, H.P. Plasma pharmacokinetics of
alfaxalone in dogs after an intravenous bolus of Alfaxan-CD RTU. Vet. Anaesth. Analg. 2006, 33, 229–236.
[CrossRef] [PubMed]
35. Muir, W.; Lerche, P.; Wiese, A.; Nelson, L.; Pasloske, K.; Whittem, T. Cardiorespiratory and anaesthetic effects
of clinical and supraclinical doses of alfaxalone in dogs. Vet. Anaesth. Analg. 2008, 35, 451–462. [CrossRef]
[PubMed]
36. Psatha, E.; Alibhai, H.I.; Jimenez-Lozano, A.; Armitage-Chan, E.; Brodbelt, D.C. Clinical efficacy and
cardiorespiratory effects of alfaxalone or diazepam/fentanyl for induction of anesthesia in dogs that are at
poor anesthetic risk. Vet. Anesth. Analg. 2011, 38, 24–36. [CrossRef] [PubMed]
37. Child, K.J.; Currie, J.P.; Davis, B.; Dodds, M.G.; Pearce, D.R.; Twissell, D.J. The pharmacological properties in
animals of CT1342-a new steroid anaesthetic agent. Br. J. Anaesth. 1971, 43, 2–13. [CrossRef]
38. Bomzon, L. A limited trial of Saffan in the dog. J. Small Anim. Pract. 1981, 22, 769–773. [CrossRef]
39. Brewster, M.E.; Estes, K.S.; Bodor, N. Development of a non-surfactant formulation for alfaxalone through
the use of chemically-modified cyclodextrins. J. Parent. Sci. Tech. 1989, 43, 262–265.
40. Veronesi, M.C.; Panzani, S.; Faustini, M.; Rota, A. An Apgar scoring system for routine assessment of
newborn puppy viability and short-term survival prognosis. Theriogenology 2009, 72, 401–407. [CrossRef]
Animals 2019, 9, 962 11 of 11
41. Veronesi, M.C. Assessment of canine neonatal viability-the Apgar score. Reprod. Dom. Anim. 2016, 51, 46–50.
[CrossRef]
42. Bolis, B.; Prandi, A.; Rota, A.; Faustini, M.; Veronesi, M.C. Cortisol fetal fluid concentrations in term pregnancy
of small-sized purebred dogs and its preliminary relation to first 24 h survival of newborns. Theriogenology
2017, 88, 264–269. [CrossRef]
43. Veronesi, M.C.; Bolis, B.; Faustini, M.; Rota, A.; Mollo, A. Biochemical composition of foetal fluids in at term,
normal developed, healthy, viable dogs and preliminary data from pathologic littermates. Theriogenology
2018, 108, 277–823. [CrossRef] [PubMed]
44. Meloni, T.; Comin, A.; Rota, A.; Peric, T.; Contri, A.; Veronesi, M.C. IGF-I and NEFA concentrations in fetal
fluids of term pregnancy dogs. Theriogenology 2014, 81, 1307–1311. [CrossRef] [PubMed]
45. Noakes, D.E. Maternal dystocia: Causes and treatment. In Veterinary reproduction and obstetrics; Noakes, D.E.,
Parkinson, T.J., England, G.C.W., Eds.; Elsevier Saunders: Philadelphia, PA, USA, 2009; pp. 232–246.
46. Posival, A.; Althoff, G.; Goericke-Pesch, S.; Wehrend, A. Perinatal mortality of puppies after caesarean section
caused by intrauterine infection. Tierarzt. Prax. Ausg. Klein. Heim. 2012, 40, 443–446.
47. Alonge, S.; Mauri, M.; Faustini, M.; Luvoni, G.C. Feto-maternal heart rate ratio in pregnant bitches: Effect of
gestational age and maternal bodyweight. Reprod. Dom. Anim. 2016, 51, 688–692. [CrossRef]
48. Gray, T.C. A reassessment of of the signs and levels of anaesthesia. Irish, J. Med. Sci. 1960, 419, 499. [CrossRef]
49. Hawthorne, A.J.; Booles, D.; Nugent, P.A.; Gettinby, G.; Wilkinson, J. Body-weight changes during growth in
puppies of different breeds. J. Nutr. 2004, 134, 2027S–2030S. [CrossRef]
50. Melandri, M.; Alonge, S.; Veronesi, M.C. Factors affecting neonatal bodyweight and growth rate in Great
Dane puppies. In Proceedings of the “19th EVSSAR congress”, Paris, France, 22–25 June 2016; p. 115.
51. Linde-Forsberg, C. Abnormalities in pregnancy, parturition, and the periparturient period. In Textbook
of Veterinary Internal Medicine: Diseases of the Cat and Dog; Ettinger, S.J., Feldman, E.C., Eds.; Saunders:
St. Louis, MI, USA, 2009; p. 1893.
52. Alonge, S.; Spalla, I.; Fanciullo, L.; Melandri, M. Pregnancy effect on echocardiographic parameters in Great
Dane bitches. Reprod. Dom. Anim. 2017, 52, 61.
53. Melandri, M.; Spalla, I.; Fanciullo, L.; Alonge, S. Preliminary results of the effect of gestational age and
fetuses number in cardiac function in Great Dane bitches. In Proceedings of the “42nd WSAVA and 23rd
FECAVA Eurocongress”, Copenhagen, Denmark, 25–28 September 2017. WSVA7-0207.
54. Melandri, M.; Spalla, I.; Alonge, S. Echocardiography in canine pregnancy: Which changes are expected?
In Proceedings of the “5th International CPP Biannual Congress”, Bologna, Italy, 22–25 February 2018; p. 23.
55. Cruz-Benedetti, I.C.; Bublot, I.; Ribas, T.; Fourel, I.; Vogl, C.; Dubois, C.; Milani, M.; Kazue Ida, K.; Portier, K.
Pharmacokinetics of intramuscular alfaxalone and its echocardiographic, cardiopulmonary and sedative
effects in healthy dogs. PLoS ONE 2018. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
